NILAY V DESAI
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism
- Where
- ROCKY MOUNT, NC
- NPI
- 1336157122
- Received
- $360,990 in 520 records, 2019 to 2025
- As principal investigator
- $44,982 of research payments to others in 5 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 51 | $44,097 |
| 2024 | General payment | 32 | $18,279 |
| 2023 | General payment | 36 | $24,849 |
| 2022 | General payment | 49 | $42,664 |
| 2021 | General payment | 74 | $40,819 |
| 2020 | General payment | 97 | $58,894 |
| 2019 | General payment | 181 | $131,385 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novo Nordisk Inc | 166 | $171,463 | 2019–2025 |
| Lilly USA, LLC | 179 | $102,493 | 2019–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 89 | $53,571 | 2019–2025 |
| Amarin Pharma, Inc. | 32 | $20,909 | 2019–2020 |
| Abbott Laboratories | 32 | $5,598 | 2021–2023 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $5,498 | 2021–2023 |
| IBSA Pharma Inc. | 2 | $1,000 | 2020–2021 |
| Amgen Inc. | 1 | $105 | 2019 |
| Medtronic MiniMed, Inc. | 1 | $91 | 2019 |
| Radius Health, Inc. | 2 | $58 | 2021 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 | 2021–2023 |
| BETA BIONICS, INC. | 1 | $29 | 2025 |
| CeQur Corporation | 2 | $29 | 2024–2025 |
| Tandem Diabetes Care, Inc. | 1 | $20 | 2020 |
| Insulet Corporation | 1 | $20 | 2022 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 | 2020 |
| Amneal Pharmaceuticals LLC | 1 | $17 | 2025 |
| LIFESCAN, INC. | 1 | $14 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 226 | $303,458 |
| Travel and Lodging | 100 | $39,002 |
| Consulting Fee | 4 | $7,175 |
| Food and Beverage | 177 | $6,303 |
| Compensation for serving as faculty or as a speaker for a medical education program | 7 | $4,925 |
| Education | 6 | $125 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | Amneal Pharmaceuticals LLC | $17 | Food and Beverage | In-kind items and services | UNITHROID Drug, ENDOCRINOLOGY | 2025 | |
| 2025-11-25 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $6 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Novo Nordisk Inc | $3,138 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-14 | Novo Nordisk Inc | $952 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-14 | Novo Nordisk Inc | $67 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-10 | Novo Nordisk Inc | $3,138 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-10 | Novo Nordisk Inc | $850 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-10 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-07 | Novo Nordisk Inc | $494 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-10-02 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-29 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-18 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-08-25 | Lilly USA, LLC | $6 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-05 | Lilly USA, LLC | $29 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-25 | BETA BIONICS, INC. | $29 | Food and Beverage | In-kind items and services | iLet Bionic Pancreas Device, Automated insulin delivery system | 2025 | |
| 2025-07-23 | Novo Nordisk Inc | $2,092 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-07-23 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-26 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-20 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-11 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-05-30 | Lilly USA, LLC | $8 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-30 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-21 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-15 | Novo Nordisk Inc | $3,022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-15 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-15 | Novo Nordisk Inc | $28 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-29 | Novo Nordisk Inc | $1,162 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $1,160 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-24 | Novo Nordisk Inc | $94 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage (2 payments) | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $4,766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $956 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $119 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-04-02 | Novo Nordisk Inc | $61 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $5,341 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $502 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $441 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $399 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $184 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-08 | Novo Nordisk Inc | $93 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-06 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-02-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Food and Beverage (2 payments) | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-02-24 | Lilly USA, LLC | $975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-18 | CeQur Corporation | $22 | Food and Beverage (3 payments) | Cash or cash equivalent | CeQur Simplicity Device, Diabetes | 2025 | |
| 2024-12-05 | CeQur Corporation | $6 | Food and Beverage | Cash or cash equivalent | CeQur Simplicity Device, Diabetes | 2024 | |
| 2024-10-09 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-08 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-10 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-09-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-09-03 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4 | Food and Beverage (2 payments) | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-12 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2024 | |
| 2024-04-18 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-04-15 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2024 | |
| 2024-04-15 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-04-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-04-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-04-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-04-01 | Novo Nordisk Inc | $1,754 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-26 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-03-25 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2024 | |
| 2024-03-15 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-03-11 | Lilly USA, LLC | $60 | Travel and Lodging | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-03-06 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2024 | |
| 2024-02-21 | Lilly USA, LLC | $87 | Travel and Lodging | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-21 | Lilly USA, LLC | $30 | Food and Beverage | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-20 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-02-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $41 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-02-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $38 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-02-15 | Lilly USA, LLC | $2,762 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-15 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2024 | |
| 2024-02-14 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $280 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-02-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $146 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-01-09 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2023-12-19 | Abbott Laboratories | $4 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2023 | |
| 2023-12-11 | SANOFI-AVENTIS U.S. LLC | $33 | Food and Beverage | In-kind items and services | TOUJEO Biological, Endocrine & Metabolic Diseases | 2023 | |
| 2023-12-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-11-28 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-11-16 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-11-08 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-11-08 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-10-05 | Abbott Laboratories | $4 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-09-25 | Lilly USA, LLC | $9 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-09-15 | Abbott Laboratories | $3 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-09-06 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-08-29 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-08-22 | Abbott Laboratories | $6 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-07-27 | Abbott Laboratories | $22 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-07-27 | Abbott Laboratories | $1 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-07-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,475 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-07-05 | Lilly USA, LLC | $1,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-07-05 | Lilly USA, LLC | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-06-23 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-06-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,475 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-06-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Education | In-kind items and services | SYNJARDY Drug, DIABETES | 2023 | |
| 2023-06-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Education | In-kind items and services | SYNJARDY Drug, DIABETES | 2023 | |
| 2023-06-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,475 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-05-31 | Novo Nordisk Inc | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-05-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-05-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-05-15 | Novo Nordisk Inc | $938 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2023 | |
| 2023-04-18 | Novo Nordisk Inc | $1,993 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-04-04 | Bayer Healthcare Pharmaceuticals Inc. | $2,010 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-03-28 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-03-28 | Abbott Laboratories | $4 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2023-03-16 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-02-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-02-14 | Abbott Laboratories | $375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2023 | |
| 2023-01-15 | Abbott Laboratories | $19 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2023 | |
| 2022-11-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-11-16 | Abbott Laboratories | $19 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-11-10 | Bayer Healthcare Pharmaceuticals Inc. | $1,608 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-renal | 2022 | |
| 2022-11-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-11-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-11-01 | Novo Nordisk Inc | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-11-01 | Novo Nordisk Inc | $748 | Travel and Lodging | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-11-01 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-10-20 | Novo Nordisk Inc | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2022 | |
| 2022-10-20 | Novo Nordisk Inc | $763 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-10-20 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-10-17 | Abbott Laboratories | $750 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-10-05 | Abbott Laboratories | $50 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-09-30 | Novo Nordisk Inc | $794 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-09-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-09-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-09-19 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-09-06 | Novo Nordisk Inc | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-09-06 | Novo Nordisk Inc | $850 | Travel and Lodging | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-19 | Novo Nordisk Inc | $2,210 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-19 | Novo Nordisk Inc | $34 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-10 | Novo Nordisk Inc | $2,210 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-10 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-08-02 | Abbott Laboratories | $3 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-07-14 | Abbott Laboratories | $6 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-06-30 | Bayer Healthcare Pharmaceuticals Inc. | $43 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2022 | |
| 2022-06-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-06-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2022 | |
| 2022-05-27 | Abbott Laboratories | $9 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-05-27 | Abbott Laboratories | $1 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-04-28 | Insulet Corporation | $20 | Food and Beverage | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2022 | |
| 2022-04-27 | Abbott Laboratories | $3 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-04-18 | Bayer Healthcare Pharmaceuticals Inc. | $1,804 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-renal | 2022 | |
| 2022-04-16 | Abbott Laboratories | $3 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-04-09 | Novo Nordisk Inc | $1,734 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rybelsus Drug, Diabetes | 2022 | |
| 2022-03-29 | Lilly USA, LLC | $975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2022 | |
| 2022-03-23 | Novo Nordisk Inc | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-23 | Novo Nordisk Inc | $745 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-23 | Novo Nordisk Inc | $73 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-09 | Novo Nordisk Inc | $3,485 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-09 | Novo Nordisk Inc | $793 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-09 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-03-04 | Abbott Laboratories | $600 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 2 Device, Diabetes Care | 2022 | |
| 2022-02-18 | Novo Nordisk Inc | $2,210 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2022 | |
| 2022-02-18 | Novo Nordisk Inc | $25 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2022-02-18 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2022 | |
| 2021-12-23 | Abbott Laboratories | $22 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-12-14 | Novo Nordisk Inc | $2,362 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-12-14 | Novo Nordisk Inc | $125 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-12-14 | Novo Nordisk Inc | $59 | Travel and Lodging | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-12-14 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-12-13 | Lilly USA, LLC | $1,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2021 | |
| 2021-12-13 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2021 | |
| 2021-12-09 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2021 | |
| 2021-12-07 | Abbott Laboratories | $750 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FreeStyle Libre Pro Device, Diabetes Care | 2021 | |
| 2021-11-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-11-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-11-09 | Abbott Laboratories | $11 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-11-02 | Abbott Laboratories | $900 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FreeStyle Libre Pro Device, Diabetes Care | 2021 | |
| 2021-10-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-10-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $33 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-10-25 | Lilly USA, LLC | $1,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TRULICITY Drug, Diabetes | 2021 | |
| 2021-10-20 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2021 | |
| 2021-10-12 | Radius Health, Inc. | $25 | Food and Beverage | In-kind items and services | Tymlos Biological, Endocrinology | 2021 | |
| 2021-10-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | $46 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-10-01 | Novo Nordisk Inc | $1,755 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-10-01 | Novo Nordisk Inc | $26 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-10-01 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-10-01 | Abbott Laboratories | $1 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 | |
| 2021-09-30 | Novo Nordisk Inc | $688 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-09-30 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TRULICITY Drug, Diabetes | 2021 | |
| 2021-09-29 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TRULICITY Drug, Diabetes | 2021 | |
| 2021-09-16 | Lilly USA, LLC | $975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2021 | |
| 2021-09-15 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | HUMULIN Drug, Diabetes | 2021 | |
| 2021-09-02 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | BAQSIMI Drug, Diabetes | 2021 | |
| 2021-08-30 | Lilly USA, LLC | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TRULICITY Drug, Diabetes | 2021 | |
| 2021-08-24 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2021 | |
| 2021-08-17 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | FreeStyle Libre 2 Device, Diabetes Care | 2021 |
The latest 200 records of 520.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2020-05-26 | SANOFI US SERVICES INC. | PMG RESEARCH INC | $11,000 | Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR | 2020 |
| 2020-05-18 | SANOFI US SERVICES INC. | PMG RESEARCH INC | $3,780 | Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR | 2020 |
| 2020-01-27 | SANOFI US SERVICES INC. | PMG RESEARCH INC | $14,202 | Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR | 2020 |
| 2020-01-21 | SANOFI US SERVICES INC. | PMG RESEARCH INC | $14,202 | Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR | 2020 |
| 2019-11-18 | SANOFI US SERVICES INC. | PMG RESEARCH INC | $1,797 | Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Rocky Mount, NC, county Nash County, NC, state North Carolina; placed by its city name.
| Measure | Place (city or town) Rocky Mount, NC | County Nash County, NC | State North Carolina |
|---|---|---|---|
| Population B01003 | 54,297 | 96,216 | 10,730,404 |
| Population, 2020 census P1 | 54,341 | 94,970 | 10,439,388 |
| Median age B01002 | 40.7 | 41.5 | 39.1 |
| Under 18 B01001 | 22.0% | 22.0% | 21.8% |
| 65 and over B01001 | 20.1% | 19.4% | 17.2% |
| Households B11001 | 23,364 | 38,797 | 4,282,345 |
| Foreign born B05002 | 3.8% | 4.0% | 9.1% |
| Median household income B19013 | $55,534 | $62,426 | $72,388 |
| Median family income B19113 | $65,550 | $79,315 | $90,290 |
| Per capita income B19301 | $31,561 | $35,344 | $41,385 |
| Poverty rate B17001 | 19.7% | 11.8% | 13.0% |
| Unemployment rate B23025 | 8.0% | 4.9% | 4.7% |
| Civilian labor force B23025 | 25,961 | 46,008 | 5,336,863 |
| Mean commute (minutes) B08013 | 20.6 | 23.7 | 25.1 |
| Bachelor's degree or higher B15003 | 22.9% | 22.1% | 35.7% |
| Housing units B25001 | 26,869 | 43,797 | 4,895,668 |
| Owner-occupied B25003 | 49.0% | 63.6% | 66.6% |
| Renters B25003 | 51.0% | 36.4% | 33.4% |
| Median home value B25077 | $165,700 | $191,000 | $288,900 |
| Median gross rent B25064 | $957 | $953 | $1,228 |
| White, not Hispanic B03002 | 26.0% | 46.3% | 60.0% |
| Black B03002 | 62.4% | 40.1% | 20.0% |
| Hispanic or Latino B03002 | 5.5% | 8.2% | 11.3% |
| Asian B03002 | 1.5% | 1.0% | 3.3% |
| American Indian and Alaska Native B03002 | 0.5% | 0.5% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Rocky Mount, NC.
Comments